{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:09:47Z","timestamp":1790611787008,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Doxorubicin (DOXO) is a highly effective chemotherapeutic drug employed for the treatment of a wide spectrum of cancers, spanning from solid tumours to haematopoietic malignancies. However, its clinical use is hampered by severe and dose-dependent cardiac side effects that ultimately lead to heart failure (HF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Mitochondrial dysfunction and oxidative stress are well-established mechanisms of DOXO-induced cardiotoxicity, although recent evidence suggests that deregulation of other biological processes, like autophagy, could be involved. It is increasingly recognized that autophagy deregulation is intimately interconnected with the initiation of detrimental cellular responses, including autosis and senescence, raising the possibility of using autophagy modulators as well as senolytics and senomorphics for preventing DOXO cardiotoxicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>This review aims at providing an overview of the signalling pathways that are common to autophagy and senescence, with a special focus on how the relationship between these two processes is deregulated in response to cardiotoxic treatments. Finally, we will discuss the potential therapeutic utility of drugs modulating autophagy and\/or senescence for counteracting DOXO cardiotoxicity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11897-021-00519-w","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T06:24:57Z","timestamp":1622701497000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity"],"prefix":"10.1007","volume":"18","author":[{"given":"Michele","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1193-5296","authenticated-orcid":false,"given":"Alessandra","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"issue":"22","key":"519_CR1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013777.","journal-title":"Circulation."},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"8863789","DOI":"10.1155\/2021\/8863789","volume":"2021","author":"R Carrasco","year":"2021","unstructured":"\u2022 Carrasco R, Castillo RL, Gormaz JG, Carrillo M, Thavendiranathan P. Role of oxidative stress in the mechanisms of anthracycline-induced cardiotoxicity: effects of preventive strategies. Oxidative medicine and cellular longevity. 2021;2021:8863789. https:\/\/doi.org\/10.1155\/2021\/8863789. Collection of new therapeutic strategies aimed to prevent antracycline-induce redox unbalance.","journal-title":"Oxidative medicine and cellular longevity"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12962-020-0205-4","volume":"18","author":"S Dewilde","year":"2020","unstructured":"Dewilde S, Carroll K, Nivelle E, Sawyer J. Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective. Cost effectiveness and resource allocation : C\/E. 2020;18:7. https:\/\/doi.org\/10.1186\/s12962-020-0205-4.","journal-title":"Cost effectiveness and resource allocation : C\/E."},{"issue":"3","key":"519_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCRESAHA.116.303791","volume":"116","author":"AM Orogo","year":"2015","unstructured":"Orogo AM, Gustafsson AB. Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease. Circulation research. 2015;116(3):489\u2013503. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303791.","journal-title":"Circulation research."},{"issue":"3","key":"519_CR5","doi-asserted-by":"publisher","first-page":"118493","DOI":"10.1016\/j.bbamcr.2019.06.007","volume":"1867","author":"M Li","year":"2020","unstructured":"\u2022 Li M, Russo M, Pirozzi F, Tocchetti CG, Ghigo A. Autophagy and cancer therapy cardiotoxicity: from molecular mechanisms to therapeutic opportunities. Biochimica et biophysica acta Molecular cell research. 2020;1867(3):118493. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.06.007. Broad overview of the role of autophagy in the context of antracyclines-induced cardiotoxicity.","journal-title":"Biochimica et biophysica acta Molecular cell research"},{"issue":"7","key":"519_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"\u2022\u2022 Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circulation research. 2020;126(7):926\u201341. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.314681. A recent overview that extensively describes the impact of autophagy\/mitophagy disturbance induced by DOXO.","journal-title":"Circulation research"},{"issue":"3","key":"519_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41418-019-0480-9","volume":"27","author":"Y Yang","year":"2020","unstructured":"Yang Y, Klionsky DJ. Autophagy and disease: unanswered questions. Cell death and differentiation. 2020;27(3):858\u201371. https:\/\/doi.org\/10.1038\/s41418-019-0480-9.","journal-title":"Cell death and differentiation."},{"key":"519_CR8","doi-asserted-by":"publisher","unstructured":"Mercurio V, Cuomo A, Cadeddu Dessalvi C, Deidda M, Di Lisi D, Novo G, et al. Redox imbalances in ageing and metabolic alterations: implications in cancer and cardiac diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC). Antioxidants. 2020;9(7). https:\/\/doi.org\/10.3390\/antiox9070641.","DOI":"10.3390\/antiox9070641"},{"issue":"12","key":"519_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.tips.2018.10.005","volume":"39","author":"J Ren","year":"2018","unstructured":"\u2022 Ren J, Zhang Y. Targeting autophagy in aging and aging-related cardiovascular diseases. Trends in pharmacological sciences. 2018;39(12):1064\u201376. https:\/\/doi.org\/10.1016\/j.tips.2018.10.005. Description of the mechanisms of autophagy-inducing molecules in prevention of senescence.","journal-title":"Trends in pharmacological sciences"},{"issue":"4","key":"519_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/ars.2020.8048","volume":"34","author":"T von Zglinicki","year":"2021","unstructured":"\u2022\u2022 von Zglinicki T, Wan T, Miwa S. Senescence in post-mitotic cells: a driver of aging? Antioxidants & redox signaling. 2021;34(4):308\u201323. https:\/\/doi.org\/10.1089\/ars.2020.8048. New emerging insights of senescent post-mitotic cells.","journal-title":"Antioxidants & redox signaling"},{"issue":"2","key":"519_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"\u2022\u2022 Demaria M, O'Leary MN, Chang J, Shao L, Liu S, Alimirah F, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer discovery. 2017;7(2):165\u201376. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0241. First experimental study showing the beneficial effect of senolytic agents against DOXO-induced cardiotoxicity.","journal-title":"Cancer discovery"},{"issue":"6","key":"519_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends in cell biology. 2018;28(6):436\u201353. https:\/\/doi.org\/10.1016\/j.tcb.2018.02.001.","journal-title":"Trends in cell biology."},{"key":"519_CR13","doi-asserted-by":"publisher","unstructured":"Chun Y, Kim J. Autophagy: an essential degradation program for cellular homeostasis and life. Cells. 2018;7(12). https:\/\/doi.org\/10.3390\/cells7120278.","DOI":"10.3390\/cells7120278"},{"issue":"4","key":"519_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","volume":"1793","author":"EL Eskelinen","year":"2009","unstructured":"Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochimica et biophysica acta. 2009;1793(4):664\u201373. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.07.014.","journal-title":"Biochimica et biophysica acta."},{"issue":"2","key":"519_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology. 2011;13(2):132\u201341. https:\/\/doi.org\/10.1038\/ncb2152.","journal-title":"Nature cell biology."},{"issue":"6","key":"519_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","volume":"122","author":"S Pattingre","year":"2005","unstructured":"Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6):927\u201339. https:\/\/doi.org\/10.1016\/j.cell.2005.07.002.","journal-title":"Cell."},{"issue":"4","key":"519_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","volume":"90","author":"B Ravikumar","year":"2010","unstructured":"Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiological reviews. 2010;90(4):1383\u2013435. https:\/\/doi.org\/10.1152\/physrev.00030.2009.","journal-title":"Physiological reviews."},{"issue":"1","key":"519_CR18","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1038\/s41598-019-46657-z","volume":"9","author":"G Runwal","year":"2019","unstructured":"Runwal G, Stamatakou E, Siddiqi FH, Puri C, Zhu Y, Rubinsztein DC. LC3-positive structures are prominent in autophagy-deficient cells. Scientific reports. 2019;9(1):10147. https:\/\/doi.org\/10.1038\/s41598-019-46657-z.","journal-title":"Scientific reports."},{"issue":"21","key":"519_CR19","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. The EMBO journal. 2000;19(21):5720\u20138. https:\/\/doi.org\/10.1093\/emboj\/19.21.5720.","journal-title":"The EMBO journal."},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annual review of genetics. 2009;43:67\u201393. https:\/\/doi.org\/10.1146\/annurev-genet-102808-114910.","journal-title":"Annual review of genetics."},{"issue":"28","key":"519_CR21","doi-asserted-by":"publisher","first-page":"46663","DOI":"10.18632\/oncotarget.16944","volume":"8","author":"N Koleini","year":"2017","unstructured":"Koleini N, Kardami E. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget. 2017;8(28):46663\u201380. https:\/\/doi.org\/10.18632\/oncotarget.16944.","journal-title":"Oncotarget"},{"issue":"7","key":"519_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4161\/auto.20527","volume":"8","author":"JS King","year":"2012","unstructured":"King JS. Autophagy across the eukaryotes: is S. cerevisiae the odd one out? Autophagy. 2012;8(7):1159\u201362. https:\/\/doi.org\/10.4161\/auto.20527.","journal-title":"Autophagy"},{"issue":"1","key":"519_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cell.2007.12.018.","journal-title":"Cell."},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yjmcc.2015.11.019","volume":"95","author":"GG Schiattarella","year":"2016","unstructured":"Schiattarella GG, Hill JA. Therapeutic targeting of autophagy in cardiovascular disease. Journal of molecular and cellular cardiology. 2016;95:86\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.11.019.","journal-title":"Journal of molecular and cellular cardiology."},{"issue":"6","key":"519_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","volume":"100","author":"Y Matsui","year":"2007","unstructured":"Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation research. 2007;100(6):914\u201322. https:\/\/doi.org\/10.1161\/01.RES.0000261924.76669.36.","journal-title":"Circulation research."},{"issue":"1","key":"519_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","volume":"23","author":"JM Berthiaume","year":"2007","unstructured":"Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell biology and toxicology. 2007;23(1):15\u201325. https:\/\/doi.org\/10.1007\/s10565-006-0140-y.","journal-title":"Cell biology and toxicology."},{"issue":"5","key":"519_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature medicine. 2007;13(5):619\u201324. https:\/\/doi.org\/10.1038\/nm1574.","journal-title":"Nature medicine."},{"issue":"24","key":"519_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.lfs.2013.10.013","volume":"93","author":"AJ Dirks-Naylor","year":"2013","unstructured":"Dirks-Naylor AJ. The role of autophagy in doxorubicin-induced cardiotoxicity. Life sciences. 2013;93(24):913\u20136.","journal-title":"Life sciences."},{"issue":"1","key":"519_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2008.01.043","volume":"134","author":"L Lu","year":"2009","unstructured":"Lu L, Wu W, Yan J, Li X, Yu H, Yu X. Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. International journal of cardiology. 2009;134(1):82\u201390. https:\/\/doi.org\/10.1016\/j.ijcard.2008.01.043.","journal-title":"International journal of cardiology."},{"issue":"1","key":"519_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1074\/jbc.M109.070037","volume":"285","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. The Journal of biological chemistry. 2010;285(1):793\u2013804. https:\/\/doi.org\/10.1074\/jbc.M109.070037.","journal-title":"The Journal of biological chemistry."},{"issue":"6","key":"519_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021104","volume":"6","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Kang YM, Tian C, Zeng Y, Jia LX, Ma X, et al. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. PloS one. 2011;6(6):e21104. https:\/\/doi.org\/10.1371\/journal.pone.0021104.","journal-title":"PloS one."},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxlet.2018.04.034","volume":"292","author":"P Luo","year":"2018","unstructured":"Luo P, Zhu Y, Chen M, Yan H, Yang B, Yang X, et al. HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy. Toxicology letters. 2018;292:115\u201322. https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.034.","journal-title":"Toxicology letters."},{"key":"519_CR33","doi-asserted-by":"publisher","unstructured":"Xu ZM, Li CB, Liu QL, Li P, Yang H. Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice. International journal of molecular sciences. 2018;19(11). https:\/\/doi.org\/10.3390\/ijms19113658.","DOI":"10.3390\/ijms19113658"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biopha.2018.07.037","volume":"109","author":"QL Zhang","year":"2019","unstructured":"Zhang QL, Yang JJ, Zhang HS. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019;109:71\u201383. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.037.","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"519_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bcp.2014.01.040","volume":"88","author":"X Wang","year":"2014","unstructured":"Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochemical pharmacology. 2014;88(3):334\u201350. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.040.","journal-title":"Biochemical pharmacology."},{"issue":"1","key":"519_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bcp.2012.10.005","volume":"85","author":"BJ Sishi","year":"2013","unstructured":"Sishi BJ, Loos B, van Rooyen J, Engelbrecht AM. Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity. Biochemical pharmacology. 2013;85(1):124\u201334. https:\/\/doi.org\/10.1016\/j.bcp.2012.10.005.","journal-title":"Biochemical pharmacology."},{"issue":"3","key":"519_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/cvr\/cvs282","volume":"96","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Takemura G, Kanamori H, Takeyama T, Watanabe T, Morishita K, et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. Cardiovascular research. 2012;96(3):456\u201365. https:\/\/doi.org\/10.1093\/cvr\/cvs282.","journal-title":"Cardiovascular research."},{"issue":"6","key":"519_CR38","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000439","volume":"2","author":"X Xu","year":"2013","unstructured":"Xu X, Bucala R, Ren J. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy. Journal of the American Heart Association. 2013;2(6):e000439. https:\/\/doi.org\/10.1161\/JAHA.113.000439.","journal-title":"Journal of the American Heart Association."},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2014.06.011","volume":"74","author":"D Dutta","year":"2014","unstructured":"Dutta D, Xu J, Dirain ML, Leeuwenburgh C. Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free radical biology & medicine. 2014;74:252\u201362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.06.011.","journal-title":"Free radical biology & medicine."},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2018.10.007","volume":"124","author":"R Song","year":"2018","unstructured":"Song R, Yang Y, Lei H, Wang G, Huang Y, Xue W, et al. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving alpha-tubulin acetylation. Journal of molecular and cellular cardiology. 2018;124:58\u201369. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.007.","journal-title":"Journal of molecular and cellular cardiology."},{"issue":"7","key":"519_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/CIRCULATIONAHA.117.030352","volume":"138","author":"M Li","year":"2018","unstructured":"Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth. Circulation. 2018;138(7):696\u2013711. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030352.","journal-title":"Circulation."},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","volume":"61","author":"KT Sawicki","year":"2021","unstructured":"\u2022\u2022 Sawicki KT, Sala V, Prever L, Hirsch E, Ardehali H, Ghigo A. Preventing and treating anthracycline cardiotoxicity: new insights. Annual review of pharmacology and toxicology. 2021;61:309\u201332. https:\/\/doi.org\/10.1146\/annurev-pharmtox-030620-104842. Up-to-date summary of mechanisms involved in DOXO-induced cardiotoxicity.","journal-title":"Annual review of pharmacology and toxicology"},{"issue":"1","key":"519_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/cvr\/cvu118","volume":"103","author":"W Zhu","year":"2014","unstructured":"Zhu W, Zhang W, Shou W, Field LJ. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovascular research. 2014;103(1):81\u20139. https:\/\/doi.org\/10.1093\/cvr\/cvu118.","journal-title":"Cardiovascular research."},{"key":"519_CR44","doi-asserted-by":"publisher","unstructured":"Nithipongvanitch R, Ittarat W, Velez JM, Zhao R, St Clair DK, Oberley TD. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2007;55(6):629-639. doi:https:\/\/doi.org\/10.1369\/jhc.6A7146.2007.","DOI":"10.1369\/jhc.6A7146.2007"},{"issue":"7334","key":"519_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature09787","volume":"470","author":"E Sahin","year":"2011","unstructured":"Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470(7334):359\u201365. https:\/\/doi.org\/10.1038\/nature09787.","journal-title":"Nature."},{"issue":"1-2","key":"519_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-005-5905-8","volume":"273","author":"Y Shizukuda","year":"2005","unstructured":"Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Molecular and cellular biochemistry. 2005;273(1-2):25\u201332. https:\/\/doi.org\/10.1007\/s11010-005-5905-8.","journal-title":"Molecular and cellular biochemistry."},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/ncomms3308","volume":"4","author":"A Hoshino","year":"2013","unstructured":"Hoshino A, Mita Y, Okawa Y, Ariyoshi M, Iwai-Kanai E, Ueyama T, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nature communications. 2013;4:2308. https:\/\/doi.org\/10.1038\/ncomms3308.","journal-title":"Nature communications."},{"issue":"7","key":"519_CR48","doi-asserted-by":"publisher","first-page":"e13171","DOI":"10.1111\/acel.13171","volume":"19","author":"PR Coryell","year":"2020","unstructured":"Coryell PR, Goraya SK, Griffin KA, Redick MA, Sisk SR, Purvis JE. Autophagy regulates the localization and degradation of p16(INK4a). Aging cell. 2020;19(7):e13171. https:\/\/doi.org\/10.1111\/acel.13171.","journal-title":"Aging cell."},{"key":"519_CR49","doi-asserted-by":"publisher","first-page":"107751","DOI":"10.1016\/j.pharmthera.2020.107751","volume":"221","author":"IY Abdelgawad","year":"2020","unstructured":"\u2022\u2022 Abdelgawad IY, Sadak KT, Lone DW, Dabour MS, Niedernhofer LJ, Zordoky BN. Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence. Pharmacology & therapeutics. 2020;221:107751. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107751. Exhaustive report about the experimental models used to study the implications of senescent cells in chemotherapy-induced cardiotoxicity and the most relevant therapeutic approach.","journal-title":"Pharmacology & therapeutics"},{"issue":"6","key":"519_CR50","doi-asserted-by":"publisher","first-page":"pkaa082","DOI":"10.1093\/jncics\/pkaa082","volume":"4","author":"SS Shachar","year":"2020","unstructured":"Shachar SS, Deal AM, Reeder-Hayes KE, Nyrop KA, Mitin N, Anders CK, et al. Effects of breast cancer adjuvant chemotherapy regimens on expression of the aging biomarker, p16(INK4a). JNCI cancer spectrum. 2020;4(6):pkaa082. https:\/\/doi.org\/10.1093\/jncics\/pkaa082.","journal-title":"JNCI cancer spectrum"},{"issue":"2","key":"519_CR51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00395-013-0334-4","volume":"108","author":"E Piegari","year":"2013","unstructured":"Piegari E, De Angelis A, Cappetta D, Russo R, Esposito G, Costantino S, et al. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. Basic research in cardiology. 2013;108(2):334. https:\/\/doi.org\/10.1007\/s00395-013-0334-4.","journal-title":"Basic research in cardiology."},{"key":"519_CR52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1748-717X-8-252","volume":"8","author":"S Marcoux","year":"2013","unstructured":"Marcoux S, Le ON, Langlois-Pelletier C, Laverdiere C, Hatami A, Robaey P, et al. Expression of the senescence marker p16INK4a in skin biopsies of acute lymphoblastic leukemia survivors: a pilot study. Radiation oncology. 2013;8:252. https:\/\/doi.org\/10.1186\/1748-717X-8-252.","journal-title":"Radiation oncology."},{"issue":"4","key":"519_CR53","doi-asserted-by":"publisher","first-page":"dju057","DOI":"10.1093\/jnci\/dju057","volume":"106","author":"HK Sanoff","year":"2014","unstructured":"Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, et al. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. Journal of the National Cancer Institute. 2014;106(4):dju057. https:\/\/doi.org\/10.1093\/jnci\/dju057.","journal-title":"Journal of the National Cancer Institute"},{"issue":"43","key":"519_CR54","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/onc.2012.640","volume":"32","author":"A Rufini","year":"2013","unstructured":"Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene. 2013;32(43):5129\u201343. https:\/\/doi.org\/10.1038\/onc.2012.640.","journal-title":"Oncogene."},{"key":"519_CR55","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Experimental cell research. 1961;25:585\u2013621. https:\/\/doi.org\/10.1016\/0014-4827(61)90192-6.","journal-title":"Experimental cell research."},{"key":"519_CR56","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nature communications. 2016;7:11190. https:\/\/doi.org\/10.1038\/ncomms11190.","journal-title":"Nature communications."},{"issue":"1","key":"519_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature medicine. 2016;22(1):78\u201383. https:\/\/doi.org\/10.1038\/nm.4010.","journal-title":"Nature medicine."},{"issue":"18","key":"519_CR58","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1128\/mcb.20.18.6741-6754.2000","volume":"20","author":"V Dulic","year":"2000","unstructured":"Dulic V, Beney GE, Frebourg G, Drullinger LF, Stein GH. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Molecular and cellular biology. 2000;20(18):6741\u201354. https:\/\/doi.org\/10.1128\/mcb.20.18.6741-6754.2000.","journal-title":"Molecular and cellular biology."},{"issue":"16","key":"519_CR59","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1093\/emboj\/cdg417","volume":"22","author":"CM Beausejour","year":"2003","unstructured":"Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. The EMBO journal. 2003;22(16):4212\u201322. https:\/\/doi.org\/10.1093\/emboj\/cdg417.","journal-title":"The EMBO journal."},{"issue":"3","key":"519_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1152\/physrev.1993.73.3.617","volume":"73","author":"VJ Cristofalo","year":"1993","unstructured":"Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiological reviews. 1993;73(3):617\u201338. https:\/\/doi.org\/10.1152\/physrev.1993.73.3.617.","journal-title":"Physiological reviews."},{"key":"519_CR61","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Sapieha P, Mallette FA. Cellular senescence in postmitotic cells: beyond growth arrest, 2018. Trends in cell biology. 28(8):595\u2013607. https:\/\/doi.org\/10.1016\/j.tcb.2018.03.003. Examines the putative pathophysiological role of post-mitotic cellular senescence.","DOI":"10.1016\/j.tcb.2018.03.003"},{"issue":"20","key":"519_CR62","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/jnci\/djq364","volume":"102","author":"JA Ewald","year":"2010","unstructured":"Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. Journal of the National Cancer Institute. 2010;102(20):1536\u201346. https:\/\/doi.org\/10.1093\/jnci\/djq364.","journal-title":"Journal of the National Cancer Institute."},{"issue":"11","key":"519_CR63","first-page":"2705","volume":"63","author":"IB Roninson","year":"2003","unstructured":"Roninson IB. Tumor cell senescence in cancer treatment. Cancer research. 2003;63(11):2705\u201315.","journal-title":"Cancer research."},{"issue":"110","key":"519_CR64","doi-asserted-by":"publisher","first-page":"ra13","DOI":"10.1126\/scisignal.2000634","volume":"3","author":"F Li","year":"2010","unstructured":"Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, et al. Apoptotic cells activate the \"phoenix rising\" pathway to promote wound healing and tissue regeneration. Science signaling. 2010;3(110):ra13. https:\/\/doi.org\/10.1126\/scisignal.2000634.","journal-title":"Science signaling"},{"issue":"6","key":"519_CR65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Developmental cell. 2014;31(6):722\u201333. https:\/\/doi.org\/10.1016\/j.devcel.2014.11.012.","journal-title":"Developmental cell."},{"issue":"Suppl 1","key":"519_CR66","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1002\/bies.201670910","volume":"38","author":"A Lujambio","year":"2016","unstructured":"Lujambio A. To clear, or not to clear (senescent cells)? That is the question. BioEssays: news and reviews in molecular, cellular and developmental biology. 2016;38(Suppl 1):S56\u201364. https:\/\/doi.org\/10.1002\/bies.201670910.","journal-title":"BioEssays: news and reviews in molecular, cellular and developmental biology"},{"key":"519_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.020","volume":"21","author":"VI Korolchuk","year":"2017","unstructured":"\u2022 Korolchuk VI, Miwa S, Carroll B, von Zglinicki T. Mitochondria in cell senescence: is mitophagy the weakest link? EBioMedicine. 2017;21:7\u201313. https:\/\/doi.org\/10.1016\/j.ebiom.2017.03.020. Highlights mechanisms leading to mitophagy disturbance in cellular senescent transition.","journal-title":"EBioMedicine"},{"issue":"2","key":"519_CR68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1474-9726.2012.00795.x","volume":"11","author":"G Nelson","year":"2012","unstructured":"Nelson G, Wordsworth J, Wang C, Jurk D, Lawless C, Martin-Ruiz C, et al. A senescent cell bystander effect: senescence-induced senescence. Aging cell. 2012;11(2):345\u20139. https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00795.x.","journal-title":"Aging cell."},{"issue":"8","key":"519_CR69","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature cell biology. 2013;15(8):978\u201390. https:\/\/doi.org\/10.1038\/ncb2784.","journal-title":"Nature cell biology."},{"issue":"1","key":"519_CR70","doi-asserted-by":"publisher","first-page":"e12848","DOI":"10.1111\/acel.12848","volume":"18","author":"PFL da Silva","year":"2019","unstructured":"\u2022\u2022 da Silva PFL, Ogrodnik M, Kucheryavenko O, Glibert J, Miwa S, Cameron K, et al. The bystander effect contributes to the accumulation of senescent cells in vivo. Aging cell. 2019;18(1):e12848. https:\/\/doi.org\/10.1111\/acel.12848. First in vivo evidence showing that senescent cells induce senescence in neighboring cells through the release of SASP factors.","journal-title":"Aging cell"},{"issue":"7","key":"519_CR71","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15252\/embj.201592862","volume":"35","author":"C Correia-Melo","year":"2016","unstructured":"Correia-Melo C, Marques FD, Anderson R, Hewitt G, Hewitt R, Cole J, et al. Mitochondria are required for pro-ageing features of the senescent phenotype. The EMBO journal. 2016;35(7):724\u201342. https:\/\/doi.org\/10.15252\/embj.201592862.","journal-title":"The EMBO journal"},{"key":"519_CR72","unstructured":"Kolesnik FA, Nikolaeva NV, Vinogradova TA, Riabokon AG. The work capacity of patients with chronic nonspecific lung diseases combined with ischemic heart disease. Vrachebnoe delo. 1989;(7):65\u20136."},{"issue":"1","key":"519_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell research. 2011;21(1):103\u201315. https:\/\/doi.org\/10.1038\/cr.2010.178.","journal-title":"Cell research."},{"key":"519_CR74","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1038\/ncomms4837","volume":"5","author":"S Miwa","year":"2014","unstructured":"Miwa S, Jow H, Baty K, Johnson A, Czapiewski R, Saretzki G, et al. Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice. Nature communications. 2014;5:3837. https:\/\/doi.org\/10.1038\/ncomms4837.","journal-title":"Nature communications."},{"issue":"21","key":"519_CR75","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.4161\/cc.7.21.6919","volume":"7","author":"ZN Demidenko","year":"2008","unstructured":"Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell cycle. 2008;7(21):3355\u201361. https:\/\/doi.org\/10.4161\/cc.7.21.6919.","journal-title":"Cell cycle."},{"issue":"9","key":"519_CR76","doi-asserted-by":"publisher","first-page":"555","DOI":"10.18632\/aging.100196","volume":"2","author":"C Wang","year":"2010","unstructured":"Wang C, Maddick M, Miwa S, Jurk D, Czapiewski R, Saretzki G, et al. Adult-onset, short-term dietary restriction reduces cell senescence in mice. Aging. 2010;2(9):555\u201366. https:\/\/doi.org\/10.18632\/aging.100196.","journal-title":"Aging"},{"key":"519_CR77","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.03.018","volume":"71","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Mi SL, Hu N, Doser TA, Sun A, Ge J, et al. Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function. Free radical biology & medicine. 2014;71:208\u201320. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.03.018.","journal-title":"Free radical biology & medicine."},{"issue":"4","key":"519_CR78","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1474-9726.2010.00586.x","volume":"9","author":"S Turdi","year":"2010","unstructured":"Turdi S, Fan X, Li J, Zhao J, Huff AF, Du M, et al. AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging cell. 2010;9(4):592\u2013606. https:\/\/doi.org\/10.1111\/j.1474-9726.2010.00586.x.","journal-title":"Aging cell."},{"issue":"11","key":"519_CR79","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3109\/00498254.2015.1034223","volume":"45","author":"G Hao","year":"2015","unstructured":"Hao G, Yu Y, Gu B, Xing Y, Xue M. Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin. Xenobiotica; the fate of foreign compounds in biological systems. 2015;45(11):1024\u20139. https:\/\/doi.org\/10.3109\/00498254.2015.1034223.","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems."},{"issue":"2","key":"519_CR80","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12012-017-9420-4","volume":"18","author":"N Zakaria","year":"2018","unstructured":"Zakaria N, Khalil SR, Awad A, Khairy GM. Quercetin reverses altered energy metabolism in the heart of rats receiving adriamycin chemotherapy. Cardiovascular toxicology. 2018;18(2):109\u201319. https:\/\/doi.org\/10.1007\/s12012-017-9420-4.","journal-title":"Cardiovascular toxicology."},{"issue":"9","key":"519_CR81","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bbadis.2007.05.002","volume":"1772","author":"H Kaiserova","year":"2007","unstructured":"Kaiserova H, Simunek T, van der Vijgh WJ, Bast A, Kvasnickova E. Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductase. Biochimica et biophysica acta. 2007;1772(9):1065\u201374. https:\/\/doi.org\/10.1016\/j.bbadis.2007.05.002.","journal-title":"Biochimica et biophysica acta."},{"issue":"2","key":"519_CR82","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.etap.2013.05.006","volume":"36","author":"AI Matouk","year":"2013","unstructured":"Matouk AI, Taye A, Heeba GH, El-Moselhy MA. Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environmental toxicology and pharmacology. 2013;36(2):443\u201350. https:\/\/doi.org\/10.1016\/j.etap.2013.05.006.","journal-title":"Environmental toxicology and pharmacology."},{"key":"519_CR83","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2015.06.040","volume":"213","author":"B Cote","year":"2015","unstructured":"Cote B, Carlson LJ, Rao DA, Alani AWG. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. Journal of controlled release: official journal of the Controlled Release Society. 2015;213:128\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2015.06.040.","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"519_CR84","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446\u201356. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069.","journal-title":"EBioMedicine."},{"key":"519_CR85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12885-016-2129-0","volume":"16","author":"R Tanos","year":"2016","unstructured":"Tanos R, Karmali D, Nalluri S, Goldsmith KC. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma. BMC cancer. 2016;16:97. https:\/\/doi.org\/10.1186\/s12885-016-2129-0.","journal-title":"BMC cancer."},{"issue":"1","key":"519_CR86","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1038\/s41467-019-12888-x","volume":"10","author":"F Triana-Martinez","year":"2019","unstructured":"Triana-Martinez F, Picallos-Rabina P, Da Silva-Alvarez S, Pietrocola F, Llanos S, Rodilla V, et al. Identification and characterization of Cardiac Glycosides as senolytic compounds. Nature communications. 2019;10(1):4731. https:\/\/doi.org\/10.1038\/s41467-019-12888-x.","journal-title":"Nature communications."},{"issue":"5","key":"519_CR87","doi-asserted-by":"publisher","first-page":"e12811","DOI":"10.1111\/acel.12811","volume":"17","author":"N Manzella","year":"2018","unstructured":"\u2022 Manzella N, Santin Y, Maggiorani D, Martini H, Douin-Echinard V, Passos JF, et al. Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy. Aging cell. 2018;17(5):e12811. https:\/\/doi.org\/10.1111\/acel.12811. Authors elucidate a new molecular mechanism that endorses mitochondria-derived ROS during premature senescence initiation.","journal-title":"Aging cell"},{"issue":"5","key":"519_CR88","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1177\/147323001103900514","volume":"39","author":"X Zhao","year":"2011","unstructured":"Zhao X, Zhang J, Tong N, Liao X, Wang E, Li Z, et al. Berberine attenuates doxorubicin-induced cardiotoxicity in mice. The Journal of international medical research. 2011;39(5):1720\u20137. https:\/\/doi.org\/10.1177\/147323001103900514.","journal-title":"The Journal of international medical research."},{"issue":"10","key":"519_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047351","volume":"7","author":"X Lv","year":"2012","unstructured":"Lv X, Yu X, Wang Y, Wang F, Li H, Wang Y, et al. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PloS one. 2012;7(10):e47351. https:\/\/doi.org\/10.1371\/journal.pone.0047351.","journal-title":"PloS one."},{"issue":"2","key":"519_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","volume":"22","author":"M Russo","year":"2021","unstructured":"\u2022 Russo M, Della Sala A, Tocchetti CG, Porporato PE, Ghigo A. Metabolic aspects of anthracycline cardiotoxicity. Current treatment options in oncology. 2021;22(2):18. https:\/\/doi.org\/10.1007\/s11864-020-00812-1. Recent overview of the detrimental impact of anthracycline treatment on cardiac metabolism.","journal-title":"Current treatment options in oncology"},{"issue":"2","key":"519_CR91","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.arr.2011.12.005","volume":"11","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing research reviews. 2012;11(2):230\u201341. https:\/\/doi.org\/10.1016\/j.arr.2011.12.005.","journal-title":"Ageing research reviews."},{"issue":"8","key":"519_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.410","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Wang Y, Zhang Z, Liu Q, Gu J. Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1\/LKB1\/AMPK pathway. Cell death & disease. 2017;8(8):e3018. https:\/\/doi.org\/10.1038\/cddis.2017.410.","journal-title":"Cell death & disease."},{"issue":"5","key":"519_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1474-9726.2006.00235.x","volume":"5","author":"T Sasaki","year":"2006","unstructured":"Sasaki T, Maier B, Bartke A, Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging cell. 2006;5(5):413\u201322. https:\/\/doi.org\/10.1111\/j.1474-9726.2006.00235.x.","journal-title":"Aging cell."},{"issue":"8","key":"519_CR94","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends in cell biology. 2014;24(8):464\u201371. https:\/\/doi.org\/10.1016\/j.tcb.2014.04.002.","journal-title":"Trends in cell biology."},{"issue":"3","key":"519_CR95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41556-019-0287-4","volume":"21","author":"T Nacarelli","year":"2019","unstructured":"Nacarelli T, Lau L, Fukumoto T, Zundell J, Fatkhutdinov N, Wu S, et al. NAD(+) metabolism governs the proinflammatory senescence-associated secretome. Nature cell biology. 2019;21(3):397\u2013407. https:\/\/doi.org\/10.1038\/s41556-019-0287-4.","journal-title":"Nature cell biology."},{"issue":"16","key":"519_CR96","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1158\/0008-5472.CAN-20-1811","volume":"80","author":"CD Wiley","year":"2020","unstructured":"Wiley CD. Bubble Bubble, Senescent cells are a cauldron of tumor trouble. Cancer research. 2020;80(16):3193\u20134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1811.","journal-title":"Cancer research."},{"issue":"10","key":"519_CR97","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/cvr\/cvy064","volume":"114","author":"N Matsumura","year":"2018","unstructured":"Matsumura N, Zordoky BN, Robertson IM, Hamza SM, Parajuli N, Soltys CM, et al. Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes. Cardiovascular research. 2018;114(10):1350\u20139. https:\/\/doi.org\/10.1093\/cvr\/cvy064.","journal-title":"Cardiovascular research."},{"issue":"10","key":"519_CR98","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cvr\/cvy108","volume":"114","author":"S Abid","year":"2018","unstructured":"\u2022 Abid S, Lipskaia L, Adnot S. Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence? Cardiovascular research. 2018;114(10):1304\u20135. https:\/\/doi.org\/10.1093\/cvr\/cvy108. This work highlights the need to target anthracycline-induced senescent cells.","journal-title":"Cardiovascular research"},{"issue":"20","key":"519_CR99","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.1111\/jcmm.15859","volume":"24","author":"WY Wu","year":"2020","unstructured":"Wu WY, Cui YK, Hong YX, Li YD, Wu Y, Li G, et al. Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1-mediated activation of AMPK\/Nrf2 signal molecules. Journal of cellular and molecular medicine. 2020;24(20):12141\u201353. https:\/\/doi.org\/10.1111\/jcmm.15859.","journal-title":"Journal of cellular and molecular medicine."},{"key":"519_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.8","volume":"1","author":"E Morselli","year":"2010","unstructured":"Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell death & disease. 2010;1:e10. https:\/\/doi.org\/10.1038\/cddis.2009.8.","journal-title":"Cell death & disease."},{"issue":"12","key":"519_CR101","doi-asserted-by":"publisher","first-page":"961","DOI":"10.18632\/aging.100110","volume":"1","author":"E Morselli","year":"2009","unstructured":"Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, et al. Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging. 2009;1(12):961\u201370. https:\/\/doi.org\/10.18632\/aging.100110.","journal-title":"Aging"},{"issue":"12","key":"519_CR102","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nm.4222","volume":"22","author":"T Eisenberg","year":"2016","unstructured":"Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nature medicine. 2016;22(12):1428\u201338. https:\/\/doi.org\/10.1038\/nm.4222.","journal-title":"Nature medicine."},{"issue":"4","key":"519_CR103","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ejhf.1439","volume":"21","author":"M Russo","year":"2019","unstructured":"Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, et al. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. European journal of heart failure. 2019;21(4):519\u201328. https:\/\/doi.org\/10.1002\/ejhf.1439.","journal-title":"European journal of heart failure."},{"key":"519_CR104","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Mu\u00f1oz-Espin R. D., Demaria M, editors. Senolytics in disease, ageing and longevity, healthy ageing and longevity book series (HAL, volume 11), Springer Nature 2020. A complete overview of the mechanisms of action and beneficial effects of senotherapy.","DOI":"10.1007\/978-3-030-44903-2"},{"key":"519_CR105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.biopha.2018.02.055","volume":"100","author":"S Li","year":"2018","unstructured":"Li S, Yuan S, Zhao Q, Wang B, Wang X, Li K. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;100:441\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.055.","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"2","key":"519_CR106","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1871520611313020020","volume":"13","author":"SZ Li","year":"2013","unstructured":"Li SZ, Li K, Zhang JH, Dong Z. The effect of quercetin on doxorubicin cytotoxicity in human breast cancer cells. Anti-cancer agents in medicinal chemistry. 2013;13(2):352\u20135. https:\/\/doi.org\/10.2174\/1871520611313020020.","journal-title":"Anti-cancer agents in medicinal chemistry."},{"issue":"4","key":"519_CR107","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging cell. 2015;14(4):644\u201358. https:\/\/doi.org\/10.1111\/acel.12344.","journal-title":"Aging cell."},{"key":"519_CR108","doi-asserted-by":"publisher","first-page":"102473","DOI":"10.1016\/j.ebiom.2019.09.053","volume":"56","author":"GM Ellison-Hughes","year":"2020","unstructured":"\u2022\u2022 Ellison-Hughes GM. First evidence that senolytics are effective at decreasing senescent cells in humans. EBioMedicine. 2020;56:102473. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.053. First clinical evidence of senolytic efficacy in depletic senescent cells in humans.","journal-title":"EBioMedicine"},{"issue":"11","key":"519_CR109","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","volume":"1","author":"A Guerrero","year":"2019","unstructured":"Guerrero A, Herranz N, Sun B, Wagner V, Gallage S, Guiho R, et al. Cardiac glycosides are broad-spectrum senolytics. Nature metabolism. 2019;1(11):1074\u201388. https:\/\/doi.org\/10.1038\/s42255-019-0122-z.","journal-title":"Nature metabolism."},{"issue":"51","key":"519_CR110","doi-asserted-by":"publisher","first-page":"20364","DOI":"10.1073\/pnas.1319661110","volume":"110","author":"Y Liu","year":"2013","unstructured":"Liu Y, Shoji-Kawata S, Sumpter RM Jr, Wei Y, Ginet V, Zhang L, et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(51):20364\u201371. https:\/\/doi.org\/10.1073\/pnas.1319661110.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America."},{"issue":"3","key":"519_CR111","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/cdd.2014.143","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell death and differentiation. 2015;22(3):367\u201376. https:\/\/doi.org\/10.1038\/cdd.2014.143.","journal-title":"Cell death and differentiation."},{"issue":"6","key":"519_CR112","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1172\/JCI132366","volume":"130","author":"J Nah","year":"2020","unstructured":"Nah J, Zhai P, Huang CY, Fernandez AF, Mareedu S, Levine B, et al. Upregulation of Rubicon promotes autosis during myocardial ischemia\/reperfusion injury. The Journal of clinical investigation. 2020;130(6):2978\u201391. https:\/\/doi.org\/10.1172\/JCI132366.","journal-title":"The Journal of clinical investigation."},{"key":"519_CR113","doi-asserted-by":"publisher","unstructured":"Jiang K, Xu Y, Wang D, Chen F, Tu Z, Qian J, et al. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis. Protein & cell. 2021. https:\/\/doi.org\/10.1007\/s13238-020-00809-4.","DOI":"10.1007\/s13238-020-00809-4"},{"key":"519_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","volume":"80","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta S, Maejima Y, Zablocki D, Sadoshima J. The role of autophagy in the heart. Annual review of physiology. 2018;80:1\u201326. https:\/\/doi.org\/10.1146\/annurev-physiol-021317-121427.","journal-title":"Annual review of physiology."},{"issue":"12","key":"519_CR115","doi-asserted-by":"publisher","first-page":"21485","DOI":"10.1002\/jcp.28895","volume":"234","author":"P Rajendran","year":"2019","unstructured":"Rajendran P, Alzahrani AM, Hanieh HN, Kumar SA, Ben Ammar R, Rengarajan T, et al. Autophagy and senescence: a new insight in selected human diseases. Journal of cellular physiology. 2019;234(12):21485\u201392. https:\/\/doi.org\/10.1002\/jcp.28895.","journal-title":"Journal of cellular physiology."}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-021-00519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-021-00519-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-021-00519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T01:03:32Z","timestamp":1628211812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-021-00519-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1007\/s11897-021-00519-w","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"19 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.G. is co-founder and stakeholder of Kither Biotech, a pharmaceutical product company focused on respiratory medicine not in conflict with statements in this review. The other authors report no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}